UPDATE: UBS Upgrades Array Technologies (ARRY) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 4.64 +0.84 (22.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.80 | 52 Week High | $7.27 | |||
| Open | $3.85 | 52 Week Low | $2.39 | |||
| Day High | $4.69 | P/E | N/A | |||
| Day Low | $3.84 | EPS | $-0.61 | |||
| Volume | 22,155,679 | |||||
